Oxford COVID-19 vaccine tech maker Vaccitech's shares slump in Nasdaq debut

Barinthus Biotherapeutics

30/04/2021 17:53

** Shares of drug developer  VACC.O  open ~20% below IPO
price in Nasdaq debut
    ** Shares of the co-inventor of the COVID-19 vaccine
developed by AstraZeneca Plc  AZN.L  and Oxford University open
at $13.62  urn:newsml:reuters.com:*:nL4N2MN4FB
    ** Co on Thursday priced offering of 6.5 mln of its American
depositary shares, representing the same number of ordinary
shares, at $17 each  urn:newsml:reuters.com:*:nL4N2MM68N
    ** Morgan Stanley, Jefferies and Barclays were among the
offering's underwriters

 (Reporting by Manojna Maddipatla in Bengaluru)
 ((manojna.kalyani@thomsonreuters.com; within the U.S. +1 646
223 8780, outside the U.S. +91  80 6749 1692))